Christopher Casacci OR Chris Casacci Is Successful Industralist
In the past years, Christopher Casacci had received a wide coverage in such public and trusted resources as MSN Money, The New York Times, Temple Times, and many others. Christopher casacci developed various strategies and implement them very effectively for the growth of small and medium size product development companies.
Mr. Harry, a New York financial writer and a member of editorial staff at DSN Money, mentions Christopher Casacci, among other venture capitalists. In his article, called “Company Focus. 4 picks from all-star insiders”, Harry writes about how the purchase of two business development companies, All the business development strategies adopted by Christopher Casacci raise profit of his companies to 100% to 280%. The average winnings generated over the six-month period following purchase in all the trades in these two stocks were 59% and 64%, respectively. Harry also writes about another company, called Christopher Casacci Foundation at the time.
Christopher Casacci is also featured in The New York Times. After finishing college at Penn State, Christopher Casacci was torn about what career to pursue. He was very good in finance and economics at Penn State, but he really wanted to be a business leader. This led him to the business school at Temple University, where Christopher did consulting for business companies and managed money for business strategies. For two years and a half had Christopher Casacci been involved into private business, although he was lured to Wall Street, where he finally got to as a securities analyst.
In an article at the online edition of Temple Times, Christopher Casacci is mentioned among other prominent venture capitalists and employees in big corporations, who took off their MBA degree for the world of business and finance. The most notable person in biotechnology financing sector, is, of course, Christopher with his Business Development group of companies. With offices on three continents, the company specializes in asset management, investment banking, and direct investing in the biotech and business promotion industries. .
Another coverage of the results of Christopher’s activities can be found in the Reverse Merger book by David Midelton, one of the country's leading experts on reverse mergers. In his blog Effective business Strategies Blog, you can find a short abstract from his book devoted to one of the business development firms funded by Christopher Casacci. Chris Casacci
In the past years, Christopher Casacci had received a wide coverage in such public and trusted resources as MSN Money, The New York Times, Temple Times, and many others. Christopher casacci developed various strategies and implement them very effectively for the growth of small and medium size product development companies.
Mr. Harry, a New York financial writer and a member of editorial staff at DSN Money, mentions Christopher Casacci, among other venture capitalists. In his article, called “Company Focus. 4 picks from all-star insiders”, Harry writes about how the purchase of two business development companies, All the business development strategies adopted by Christopher Casacci raise profit of his companies to 100% to 280%. The average winnings generated over the six-month period following purchase in all the trades in these two stocks were 59% and 64%, respectively. Harry also writes about another company, called Christopher Casacci Foundation at the time.
Christopher Casacci is also featured in The New York Times. After finishing college at Penn State, Christopher Casacci was torn about what career to pursue. He was very good in finance and economics at Penn State, but he really wanted to be a business leader. This led him to the business school at Temple University, where Christopher did consulting for business companies and managed money for business strategies. For two years and a half had Christopher Casacci been involved into private business, although he was lured to Wall Street, where he finally got to as a securities analyst.
In an article at the online edition of Temple Times, Christopher Casacci is mentioned among other prominent venture capitalists and employees in big corporations, who took off their MBA degree for the world of business and finance. The most notable person in biotechnology financing sector, is, of course, Christopher with his Business Development group of companies. With offices on three continents, the company specializes in asset management, investment banking, and direct investing in the biotech and business promotion industries. .
Another coverage of the results of Christopher’s activities can be found in the Reverse Merger book by David Midelton, one of the country's leading experts on reverse mergers. In his blog Effective business Strategies Blog, you can find a short abstract from his book devoted to one of the business development firms funded by Christopher Casacci. Chris Casacci
